Home›People›James Davie
JD

James Davie

President & CEO, director at MalarVx.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Aug 25, 2026·Suggest an edit

About James Davie

James Davie is a president & CEO, director at MalarVx.

James Davie first appears on SEC filings in 2012.

Experience

This experience comes from James Davie's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Davie in the role, so the role may have started earlier or lasted longer.

MalarVx, Inc. Current
President & CEO, director
President/ CEO (2013 – Present)
2012 – Present · Seattle, WA
Develops vaccines to prevent malaria in people.
AttoDx, Inc. Current
President/CEO
2009 – Present
Blood Cell Storage, Inc.
President
2004 – 2008

Key Colleagues at Startups

The people James Davie works with at each company, as listed on that company's latest Form D.

MalarVx, Inc. · Form D, Aug 25, 2026
JH
Jodi Herczeg
Corporate Counsel

Sources

  1. SECMalarVx, Inc. Form D, filed Aug 25, 2026